source
- AI-focused biotech firms drive biopharma toward a 'fail-fast' drug development modelAI is quickly becoming a central force in drug development as tech capital pours into biopharma, reshaping how new medicines are discovered. Tyrone Lam, chief business officer at GATC Health, says…
- Why a missed promotion isn't always about youA missed promotion can feel like a verdict on your potential. But people and organizations do not always develop at the same pace. Executive coach Angela Justice breaks down what a missed promotion…BioSpace · 24m ago↗ source
- Eli Lilly fronts $2 billion for vaccine biotech deals as Infinimmune secures $75 million funding